Management of Seizures Secondary to Hypoxic Brain Injury After Cardiac Arrest
Perform immediate EEG monitoring and treat seizures aggressively with standard anticonvulsant regimens used for status epilepticus, while recognizing that these seizures are often refractory to treatment and carry a poor prognosis. 1
Immediate Diagnostic Approach
Obtain EEG as soon as possible (Class I recommendation) in all comatose post-cardiac arrest patients, as seizures occur in 12-22% of these patients and are frequently nonconvulsive, making clinical detection unreliable. 1
- Implement continuous EEG monitoring rather than intermittent studies, as nonconvulsive status epilepticus may be the reason patients remain comatose and can be missed without ongoing surveillance. 1
- Seizures typically commence during the late hypothermic or rewarming periods if therapeutic hypothermia is being used. 2
- Up to 67% of seizures are nonconvulsive and 78% are electrographically generalized, emphasizing the critical need for EEG rather than relying on clinical observation alone. 2
Treatment Algorithm
First-Line Management
Use the same anticonvulsant regimens employed for status epilepticus from other etiologies (Class IIb recommendation), as no specific drug or combination has proven superior in the post-cardiac arrest population. 1
Recommended anticonvulsant options include: 1
- Sodium valproate
- Levetiracetam
- Phenytoin
- Benzodiazepines (lorazepam, clonazepam)
- Propofol
- Barbiturates
Special Considerations for Myoclonus
For myoclonic seizures specifically, phenytoin is often ineffective. 1
Preferred antimyoclonic agents include: 1
- Propofol (effective for suppressing post-anoxic myoclonus)
- Clonazepam
- Sodium valproate
- Levetiracetam
Refractory Cases
Be prepared that post-cardiac arrest seizures are frequently refractory to traditional anticonvulsant agents, requiring escalation to multiple medications or general anesthetics. 1, 3
Critical Pitfalls to Avoid
Do NOT use prophylactic anticonvulsants. Two randomized trials comparing thiopental and diazepam to placebo showed no outcome benefit when administered prophylactically after ROSC, and prophylaxis carries risk of adverse effects without proven benefit. 1
Do NOT delay treatment while awaiting EEG confirmation if clinical seizures are evident, as prolonged epileptiform discharges cause secondary brain injury through increased cerebral metabolic demand and tissue hypoxia. 1, 4
Do NOT assume seizure control means good prognosis. Among 47 post-cardiac arrest patients treated for seizures or status epilepticus in case series, only 1 survived with good neurologic function, highlighting the grave prognostic implications. 1
Concurrent Neuroprotective Management
While treating seizures, simultaneously optimize other factors that influence secondary brain injury:
- Maintain normocarbia (PaCO₂ 35-45 mmHg) to prevent cerebral vasoconstriction from hypocapnia. 1, 3
- Titrate oxygen to achieve arterial saturation of 94% to avoid both hypoxemia and hyperoxia-mediated injury. 3, 5
- Prevent hyperthermia after rewarming from targeted temperature management, as fever exacerbates neurologic injury. 1, 3
- Maintain adequate cerebral perfusion pressure by avoiding hypotension (systolic BP >100 mmHg). 3
Prognostic Context
Understand that seizures and status epilepticus are associated with poor neurological outcomes, but individual patients may survive with good function, necessitating prolonged observation after seizure treatment before making prognostic determinations. 1, 3
Brain injury accounts for 68% of deaths after out-of-hospital cardiac arrest, with the pathophysiology involving a complex ischemia-reperfusion cascade executed over hours to days after ROSC. 3, 6 Seizures represent one manifestation of this ongoing secondary injury process. 1, 3
Avoid premature prognostication, as many predictors of poor outcome are unreliable, especially in patients treated with therapeutic hypothermia. 3, 5